Urge Your Representative to Support Access to Alzheimer’s Treatments
The Centers for Medicare & Medicaid Services (CMS) is still blocking coverage of FDA-approved treatments targeting amyloid for Alzheimer’s. Ask your U.S. representative to urge CMS to change this decision. Take action today!
Take Action
We need your voice to advance policies. Learn about our active campaigns.
Your Impact
Learn how people like you are making a difference in the fight against Alzheimer’s and all dementia.
Our Impact
Alzheimer’s disease is one of the most critical public health issues in America. That’s why the Alzheimer’s Impact Movement (AIM), the Alzheimer’s Association and our advocates are unrelenting. We fight to support Alzheimer's and dementia research funding and advance bipartisan legislation that will have a positive and meaningful impact on people living with Alzheimer's and their caregivers today and in the future.
With the support of volunteer advocates and bipartisan congressional champions we’re making an impact. Help us persuade policymakers to make Alzheimer’s a national priority.
6M
We advocate for the more than 6 million Americans living with Alzheimer’s, a progressive and fatal brain disease.
$3.7B
We’ve increased the federal investment in Alzheimer’s and dementia research funding more than seven-fold in the last decade.
11M
More than 11 million Americans provide unpaid care for people living with Alzheimer’s or other dementias.
Latest News
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy and clinical benefit of lecanemab (Leqembi™, Eisai) as p...
Alzheimer’s Policy in the States
Across the nation AIM advocates are working to advance public policies to improve the lives of individuals and families impacted by Alzheimer’s and all other dementia. Learn about Alzheimer’s policies and advocacy in your state.